A selective detection of lysophosphatidylcholine in dried blood spots for diagnosis of adrenoleukodystrophy by LC-MS/MS

[1]  G. Raymond,et al.  Newborn screening for X-linked adrenoleukodystrophy in New York State: diagnostic protocol, surveillance protocol and treatment guidelines. , 2015, Molecular genetics and metabolism.

[2]  R. Wanders,et al.  X-linked adrenoleukodystrophy in women: a cross-sectional cohort study. , 2014, Brain : a journal of neurology.

[3]  V. D. De Jesús,et al.  Improved analysis of C26:0-lysophosphatidylcholine in dried-blood spots via negative ion mode HPLC-ESI-MS/MS for X-linked adrenoleukodystrophy newborn screening. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[4]  A. Moser,et al.  Combined extraction of acyl carnitines and 26:0 lysophosphatidylcholine from dried blood spots: prospective newborn screening for X-linked adrenoleukodystrophy. , 2012, Molecular genetics and metabolism.

[5]  Manfred Schmidt,et al.  Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy , 2009, Science.

[6]  A. Moser,et al.  Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method. , 2009, Molecular genetics and metabolism.

[7]  H. Moser,et al.  Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study , 2007, The Lancet Neurology.

[8]  Hugo Moser,et al.  Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings. , 2006, Molecular genetics and metabolism.

[9]  H. Moser,et al.  Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls , 1999, Annals of neurology.

[10]  H. Moser,et al.  Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. , 1997, Brain : a journal of neurology.

[11]  R. Wanders,et al.  Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata. , 1993, Clinical chemistry.

[12]  H. Moser,et al.  Adrenoleukodystrophy , 1998, Neurology.

[13]  V. D. De Jesús,et al.  Simultaneous quantitation of hexacosanoyl lysophosphatidylcholine, amino acids, acylcarnitines, and succinylacetone during FIA-ESI-MS/MS analysis of dried blood spot extracts for newborn screening. , 2016, Clinical biochemistry.

[14]  V. D. De Jesús,et al.  The stability of hexacosanoyl lysophosphatidylcholine in dried-blood spot quality control materials for X-linked adrenoleukodystrophy newborn screening. , 2015, Clinical biochemistry.

[15]  A. Moser,et al.  Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy. , 2015, Molecular genetics and metabolism.

[16]  A. Moser,et al.  Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible. , 2014, Molecular genetics and metabolism.